Ayurvedic Whole System Is Effective For Rheumatoid Arthritis, Reveals Study

A recent study by leading researchers from esteemed institutions has highlighted the notable effectiveness of the Ayurvedic Whole System (AWS) in managing rheumatoid arthritis (RA). The research shows that AWS not only relieves RA symptoms, but also promotes a metabolic shift towards normalisation, presenting a promising complementary option to traditional treatments.

New Delhi: A new scientific study conducted by a group of senior researchers from reputed research institutions has revealed the significant effectiveness of the Ayurvedic Whole System (AWS) in the management of rheumatoid arthritis (RA), a chronic autoimmune disorder affecting millions worldwide.

This pioneering research demonstrates that AWS not only alleviates the symptoms of RA but also induces a metabolic shift towards normalisation in patients, offering a promising complementary approach to conventional treatments.

This breakthrough underscores the potential of integrating traditional Ayurvedic practices with modern medical approaches to improve patient outcomes in chronic conditions like rheumatoid arthritis, the Ministry of Ayush said.

The study was conducted by research institutions including Arthritis Treatment and Advanced Research Center (A-ATARC), Department of Kaya Chikitsa, State Ayurvedic College and Hospital, Lucknow University; Centre of Biomedical Research (CBMR), SGPGIMS Campus, Lucknow; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad.

“This study is significant from the perspective of possible pathology reversal in case of RA being treated with a whole system Ayurveda approach. This endorses ayurvedic concepts of ‘Samprapti Vighatan’ where a pathogenesis – disease complex is dismantled and ‘Doshas’ are brought back to normality,” mentioned the first author Dr Sanjeev Rastogi.

Published in the PubMed-indexed research journal, Journal of Ayurveda and Integrated Medicine (JAIM), the study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention.

There was a notable reduction in Disease Activity Score-28 Erythrocyte Sedimentation Rate (DAS-28 ESR), as well as decreases in both the total number of swollen and tender joints. Additionally, the Ama Activity Measure (AAM) Score, which assesses the presence of toxins in the body, also showed a significant reduction post-intervention.

The research further explored the metabolic profiles of RA patients, comparing them to healthy controls. At the study's outset, RA patients exhibited elevated levels of certain metabolites, including succinate, lysine, mannose, creatine, and 3-Hydroxybutyrate (3-HB), alongside decreased alanine levels. However, following AWS treatment, these metabolic markers began to shift towards the levels observed in healthy individuals, indicating a return to a more balanced metabolic state.

As per the researchers, this study is the first of its kind to clearly demonstrate the clinical efficacy of AWS in managing RA. The intervention not only reduced symptoms but also promoted a metabolic environment conducive to homeostasis, potentially leading to long-term benefits for RA patients.